510(k) Report

FDA applicant

DNA Genotek, Inc.

Ottawa, CA8 decisions2011–20261 recall

FDA records 8 decisions for DNA Genotek, Inc. (Ottawa, CA) from 2011 to 2026: 7 510(k) clearances and 1 De Novo grant. Most are in product codes OYJ (Dna Specimen Collection, Saliva) and QPO (Device To Preserve And Stabilize Relative…). Its devices cite 9 predicates, 7 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided DNA Genotek, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2011: 12015: 12016: 22020: 12021: 12022: 12026 (partial year): 1
2011high 2 (2016) · low 0 (2012)2026

2026 so far, outlined.

Recalls per year

1in 2022

2022: 1
2011high 1 (2022) · low 0 (2011)2026

Class I Class II/III not classified

FIG. 1 — DNA Genotek, Inc. by year, 2011–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like DNA Genotek, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report